Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T): A Prospective, Multi-center, Double-blind, Randomized, Study to Evaluate Reduction in Postoperative Bleeding by Removal of Ticagrelor with the Intraoperative use of the DrugSorb-ATR Device
|Effective start/end date||5/1/22 → 12/31/25|
- CYTOSORBENTS CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.